Synapse - Works

Results (2809)

Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Figlin, R. A.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Negrier, S.; Huang, X.; Kim, S. T.; Chen, I.; Motzer, R. J.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Hypoxia-inducible factor (HIF) 1α and 2α levels in cell lines and human tumor predicts response to sunitinib in renal cell carcinoma (RCC)

Meeting Abstract

Patel, P. H.; Chadalavada, R. S.; Ishill, N. M.; Patil, S.; Reuter, V. E.; Motzer, R. J.; Chaganti, R. S.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Evaluation of soluble B7x as a serum marker in patients with clear cell renal cell carcinoma

Meeting Abstract

Thompson, R. H.; Zang, X.; Lohse, C. M.; Leibovich, B. C.; Slovin, S. F.; Reuter, V. E.; Blute, M. L.; Russo, P.; Kwon, E. D.; Allison, J. P.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Hereditary diffuse gastric cancer (HDGC): Clinical characteristics of a prospective cohort

Meeting Abstract

Shah, M. A.; Sheehy, E.; Harlan, M.; Randazzo, J.; Perera, R. J.; Pascarelli, K.; Kemeny, M. M.; Schrag, D.; Coit, D. G.; Kelsen, D. P.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Survival after resection of liver metastases from colorectal cancer with poor clinical risk factors using adjuvant systemic plus hepatic arterial therapy

Meeting Abstract

Kemeny, N. E.; Capanu, M.; Fong, Y.; Haviland, D.; Jarnagin, W. R.; DeMatteo, R. P.; D'Angelica, M. I.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Use of SUVmax to predict response to neoadjuvant chemoradiotherapy in patients with adenocarcinoma of the distal esophagus and GE junction

Meeting Abstract

Rizk, N. P.; Bains, M. S.; Park, B. J.; Flores, R. M.; Downey, R. J.; Goodman, K.; Ilson, D. H.; Rusch, V. W.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Preliminary activity of XL880, a dual MET/VEGFR2 inhibitor, in MET amplified poorly differentiated gastric cancer (PDGC): Interim results of a multicenter phase II study

Meeting Abstract

Jhawer, M. P.; Kindler, H. L.; Wainberg, Z. A.; Hecht, J. R.; Kerr, R. O.; Ford, J. M.; Henderson, C.; Mueller, T.; Keer, H. N.; Shah, M. A.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Which adjuvant systemic treatments (AdjRx) would medical oncologists (MOs) wish to receive if they had colon cancer (CCa)? A survey of 150 physicians

Meeting Abstract

Love, N.; Meropol, N. J.; Ravdin, P. M.; Bylund, C.; Ellis, L. M.; Grothey, A.; Lenz, H. J.; Marshall, J. L.; Curly, S. A.; Paley, D.; more...
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Hepatic arterial infusional (HAI) therapy in patients with unresectable primary liver cancer: Use of dynamic contrast enhanced MRI to evaluate response

Meeting Abstract

Jarnagin, W. R.; Schwartz, L. H.; Gultekin, D. H.; Gonen, M.; Haviland, D.; Blumgart, L. H.; D'Angelica, M. I.; Fong, Y.; DeMatteo, R. P.; Kemeny, N. E.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis?

Meeting Abstract

Abou-Alfa, G. K.; Amadori, D.; Santoro, A.; Figer, A.; De Greve, J.; Lathia, C.; Voliotis, D.; Anderson, S.; Moscovici, M.; Ricci, S.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save